• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M
Analysts recorded a surge of interest in the decentralized platform Farcaster

Analysts recorded a surge of interest in the decentralized platform Farcaster

user avatar

by Max Nevskyi

2 years ago


The Farcaster platform, focusing on cryptocurrency services, has caught the attention of The Block analysts by achieving a total revenue of $600,000. This success is compared to the popularity of Friend.tech, highlighting the growing interest in using cryptocurrency platforms. Researchers identify two main waves of hype around Farcaster: the first began in December 2023 with an increase in the number of users willing to pay for data storage, and the second in late January 2024, with the launch of the Frames tool, which significantly increased the number of registrations and activity on the platform.

Frames, introducing a built-in monetization feature for actions, allowed users to offer NFTs in exchange for subscriptions and reposts, attracting significant attention from the crypto community. Unlike other social networks, Farcaster offers paid access to its services, charging $5 per year for data storage, including posts, reactions, and subscriptions, with part of the funds going to support the platform and pay transaction fees.

This approach to monetization and the active use of blockchain technologies to promote products and reward users reflects Farcaster's ambition to become a key player in the Web3 market, offering innovative solutions for the cryptocurrency community.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.